BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21884966)

  • 1. Molecular mechanisms of polycystic kidney disease.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1201. PubMed ID: 21884966
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the understanding of polycystic kidney disease.
    Bacallao RL; Carone FA
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):377-83. PubMed ID: 9263688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic kidney disease.
    Igarashi P; Somlo S
    J Am Soc Nephrol; 2007 May; 18(5):1371-3. PubMed ID: 17429047
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the understanding of polycystic kidney disease.
    Torres VE; Harris PC
    Nat Rev Nephrol; 2019 Feb; 15(2):70-72. PubMed ID: 30607031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot Study of the Occurrence of Somatic Mutations in Ciliary Signalling Pathways as a Contribution Factor to Autosomal Dominant Polycystic Kidney Development.
    Skalická K; Hrčková G; Vaská A; Baranyaiová A; Janega P; Žilinská Z; Daniš D; Kovács L
    Folia Biol (Praha); 2017; 63(5-6):174-181. PubMed ID: 29687770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated.
    Watnick TJ; Germino GG
    Nat Rev Nephrol; 2013 May; 9(5):249-50. PubMed ID: 23567275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mutation detection of PKD1 gene in patients with autosomal dominant polycystic kidney diseases].
    Li L; Li LY; Zhong CG; Gao BD; Lu GX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):666-9. PubMed ID: 18067079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gretchen question in autosomal-dominant polycystic kidney disease research.
    Luft FC
    J Mol Med (Berl); 2011 Mar; 89(3):247-50. PubMed ID: 21301792
    [No Abstract]   [Full Text] [Related]  

  • 11. An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs.
    Koslowski S; Latapy C; Auvray P; Blondel M; Meijer L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular biology of polycystic kidney disease.
    Murcia NS; Woychik RP; Avner ED
    Pediatr Nephrol; 1998 Nov; 12(9):721-6. PubMed ID: 9874315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotrimeric G protein signaling in polycystic kidney disease.
    Hama T; Park F
    Physiol Genomics; 2016 Jul; 48(7):429-45. PubMed ID: 27199453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.
    Harris PC; Torres VE
    J Clin Invest; 2014 Jun; 124(6):2315-24. PubMed ID: 24892705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of polycystic kidney disease.
    Wilson PD
    Curr Top Dev Biol; 2008; 84():311-50. PubMed ID: 19186247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR signaling in polycystic kidney disease.
    Ibraghimov-Beskrovnaya O; Natoli TA
    Trends Mol Med; 2011 Nov; 17(11):625-33. PubMed ID: 21775207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic kidney disease: new knowledge and future promises.
    Foo JN; Xia Y
    Curr Opin Genet Dev; 2019 Jun; 56():69-75. PubMed ID: 31476629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is autophagy the culprit of cystogenesis in polycystic kidney disease?
    Wang S; Dong Z
    EBioMedicine; 2020 Nov; 61():103043. PubMed ID: 33038761
    [No Abstract]   [Full Text] [Related]  

  • 19. Signal transduction. Mating, channels and kidney cysts.
    Emmons SW; Somlo S
    Nature; 1999 Sep; 401(6751):339-40. PubMed ID: 10517627
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease.
    Nigro E; D'Arco D; Moscatelli F; Pisani A; Amicone M; Riccio E; Capuano I; Argentino F; Monda M; Messina G; Daniele A; Polito R
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.